Literature DB >> 893663

Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.

V H Donaldson, J Kleniewski, H Saito, J K Sayed.   

Abstract

Plasma from an individual with a hereditary deficiency of kininogens is deficient in kininogen antigens; heterozygous relatives are partially deficient in plasma kininogen antigens. In addition, plasma from the proband is partially deficient in functional and antigenic properties of a plasma prekallikrein, and the relatives heterozygous for kininogen deficiency are also partially deficient in the plasma prekallikrein. It is possible that the defects are both inherited and that the inheritance of a deficiency of prekallikrein is genetically linked to the inheritance of a deficiency of kininogen. Alternatively, it is possible that the deficiency of prekallikrein may be due to its hypercatabolism which could be a consequence of a deficiency of high molecular weight kininogen that may stabilize the prekallikrein in plasma. Evidence to support this possibility is presented by the fact that prekallikrein and high molecular weight kininogen apparently exist as a complex in normal plasma, because monospecific antiserum to kininogen removed both high molecular weight kininogen and prekallikrein from plasma, and vice versa. Moreover, prekallikrein was not adsorbed from kininogen-deficient plasma by antiserum to kininogen unless high molecular weight kininogen was first added to the plasma. Low molecular weight kininogen did not participate in these reactions.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 893663      PMCID: PMC372402          DOI: 10.1172/JCI108809

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Partial purification and characterization of contact activation cofactor.

Authors:  S Schiffman; P Lee
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

2.  Guanosine 3':5'-cyclic monophosphate binding proteins in rat tissues.

Authors:  T M Lincoln; C L Hall; C R Park; J D Corbin
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

3.  Defective esterase and kinin-forming activity in human Fletcher trait plasma. A fraction rich in kallikreinlike activity.

Authors:  V H Donaldson; H Saito; O D Ratnoff
Journal:  Circ Res       Date:  1974-05       Impact factor: 17.367

4.  Defective activation of clotting, fibrinolytic, and permeability-enhancing systems in human Fletcher trait plasma.

Authors:  H Saito; O D Ratnoff; V H Donaldson
Journal:  Circ Res       Date:  1974-05       Impact factor: 17.367

5.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

6.  Flaujeac trait. Deficiency of human plasma kininogen.

Authors:  K D Wuepper; D R Miller; M J Lacombe
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

7.  Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.

Authors:  R W Colman; A Bagdasarian; R C Talamo; C F Scott; M Seavey; J A Guimaraes; J V Pierce; A P Kaplan
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

8.  Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.

Authors:  V H Donaldson; H I Glueck; M A Miller; H Z Movat; F Habal
Journal:  J Lab Clin Med       Date:  1976-02

9.  Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.

Authors:  R J Mandle; R W Colman; A P Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

10.  Prekallikrein deficiency in man.

Authors:  K D Wuepper
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more
  9 in total

1.  Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma.

Authors:  Coen Maas; Joost C M Meijers; J Arnoud Marquart; Kamran Bakhtiari; Cees Weeterings; Philip G de Groot; Rolf T Urbanus
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

2.  Limited role of kininogen in the host response during gram-negative pneumonia-derived sepsis.

Authors:  Chao Ding; Cornelis van 't Veer; Joris J T H Roelofs; Meenal Shukla; Keith R McCrae; Alexey S Revenko; Jeff Crosby; Tom van der Poll
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-11-09       Impact factor: 5.464

3.  The concentration of high molecular weight kininogen antigen in homogenates of various human tissues.

Authors:  J Kleniewski; M Bogumił-Oczkowska
Journal:  Experientia       Date:  1980-03-15

4.  Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma.

Authors:  C F Scott; R W Colman
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

5.  Endothelial cells produce a substance that inhibits contact activation of coagulation by blocking the activation of Hageman factor.

Authors:  J Kleniewski; V H Donaldson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

6.  Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities.

Authors:  L R Shoemaker; S J Schurman; V H Donaldson; A E Davis
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

Review 7.  Human plasma kallikrein-kinin system: physiological and biochemical parameters.

Authors:  J W Bryant; Z Shariat-Madar
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2009-07

8.  Kininogen supports inflammation and bacterial spreading during Streptococccus Pyogenes Sepsis.

Authors:  Juliane Köhler; Claudia Maletzki; Dirk Koczan; Marcus Frank; Armin Springer; Carolin Steffen; Alexey S Revenko; A Robert MacLeod; Stefan Mikkat; Bernd Kreikemeyer; Sonja Oehmcke-Hecht
Journal:  EBioMedicine       Date:  2020-07-21       Impact factor: 8.143

9.  Granulocyte elastase cleaves human high molecular weight kininogen and destroys its clot-promoting activity.

Authors:  J Kleniewski; V Donaldson
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.